Suchergebnisse - "Cheng, Zhifeng"

PubPharm (44)

1

Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy : A Phase 3 Randomized Clinical Trial in China

enthalten in: Diabetes | 2024

von Guo, L. | Pan, Q. | Cheng, Z. | +10

2

Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes : A multicentre, randomized, double-blind, placebo-controlled, phase 2 trial

enthalten in: Diabetes, obesity & metabolism | 2024

von Li, Y. | Cheng, Z. | Lu, W. | +19

3

Deciphering Immune-Related Gene Signatures in Diabetic Retinopathy : Insights from In Silico Analysis and In vitro Experiment

enthalten in: Current pharmaceutical biotechnology | 2024

von Xia, N. | Zhao, Q. | Xu, J. | +1

4

Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus : A 24‐week, randomized, double‐blind, active‐controlled, phase 3 trial

enthalten in: Journal of Diabetes | 2024

von Xie, L. | Han, J. | Cheng, Z. | +12

5

Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes : A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

enthalten in: Diabetes care | 2024

von Zhang, B. | Cheng, Z. | Chen, J. | +23

6

Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus : A 24-week, randomized, double-blind, active-controlled, phase 3 trial

enthalten in: Journal of diabetes | 2024

von Xie, L. | Han, J. | Cheng, Z. | +12

7

Efficacy and safety of adding once-weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients (AWARD-CHN3) : A randomized, double-blind, placebo-controlled, phase III trial

enthalten in: Diabetes, obesity & metabolism | 2023

von Wang, W. | Yan, X. | Cheng, Z. | +5

8

A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity

enthalten in: Nature communications | 2023

von Ji, L. | Jiang, H. | Cheng, Z. | +18

9

A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy

enthalten in: Diabetes, obesity & metabolism | 2023

von Ji, L. | Lu, J. | Gao, L. | +12

10

IL‑37 suppresses macrophage ferroptosis to attenuate diabetic atherosclerosis via the NRF2 pathway

enthalten in: Experimental and therapeutic medicine | 2023

von Xu, J. | Han, X. | Xia, N. | +2

1
2
3
4
5
Nächster »
[5]